MaraBio and Their Mission to Reduce the Severe Effects of Autism
)
)
In this episode of The Venari Podcast,Michael PauldiscussesMARAbio's mission to mitigate the severe effects of autism.
Leveraging a ground-breaking discovery in immunology, MaraBio aims to detect, treat, and potentially prevent a subtype of autism caused by maternal autoantibodies. Paul shares his journey from research at Harvard Medical School to leading MaraBio, emphasizing the company's focus on precision medicine and the development of diagnostic tests to improve early intervention and outcomes for autism.
Tags:
- The Venari Podcast
- Technology
- Leadership
)
Cristian Owen joined Venari Partners in 2019. An expert in recruitment for digital health, he has been a trusted partner to many emerging and high-growth healthtech companies across the US and Europe. This spans SaaS, digital therapeutics, AI, virtual care, data (RWE), and healthcare IT, which he uses to help companies build high-performing leadership teams in strategy, BD, operations, and commercial roles. Cristian is well placed to advise on US GTM expansion for European healthtech companies, C-suite, VP-, and director-level recruitment, board appointments, and succession planning. He also provides specialised solutions including interim solutions, market mapping, compensation benchmarking, and leadership and organisational assessments. Outside of Venari Partners, as a former chef, he has a tremendous passion for food and loves to experiment with cooking and eating as many different cuisines as possible.
View Full Profile)
)
)
)
)
